연구동향 분석

In Vitro Activity of Tedizolid Against Gram-Positive Bacteria in Patients With Skin and Skin Structure Infections and Hospital-Acquired Pneumonia: A Korean Multicenter Study

이양순 용동은 이경원 홍성국 최성학 임원빈 2015년

논문상세정보
인용/피인용
' In Vitro Activity of Tedizolid Against Gram-Positive Bacteria in Patients With Skin and Skin Structure Infections and Hospital-Acquired Pneumonia: A Korean Multicenter Study' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 의학
  • gram-positive bacteria
  • infection
  • pneumonia
  • skin
  • soft tissue
  • tedizolid
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
8,060 0

0.0%

' In Vitro Activity of Tedizolid Against Gram-Positive Bacteria in Patients With Skin and Skin Structure Infections and Hospital-Acquired Pneumonia: A Korean Multicenter Study' 의 참고문헌

  • Update on the global number of vancomycin-resistant Staphylococcus aureus (VRSA) strains
    Moravvej Z Int J Antimicrob Agents 42 : 370 ~ 371 [2013]
  • Update on the global number of vancomycin-resistant Staphylococcus aureus (VRSA) strains
    Moravvej Z Int J Antimicrob Agents 42 370-371 [2013]
  • The emerging problem of linezolid-resistant Staphylococcus
    Gu B J Antimicrob Chemother 68 : 4 ~ 11 [2013]
  • The emerging problem of linezolid-resistant Staphylococcus
    Gu B J Antimicrob Chemother 68 4-11 [2013]
  • Tedizolid: a novel oxazolidinone for Gram-positive infections
    Moellering RC Jr. Clin Infect Dis 58 (S1) : S1 ~ 3 [2014]
  • Tedizolid: a novel oxazolidinone for Gram-positive infections
    Moellering RC Jr. Clin Infect Dis 58 S1 S1-3 [2014]
  • Tedizolid: a new oxazolidinone antimicrobial
    Kisgen JJ Am J Health Syst Pharm 71 : 621 ~ 633 [2014]
  • Tedizolid: a new oxazolidinone antimicrobial
    Kisgen JJ Am J Health Syst Pharm 71 621-633 [2014]
  • Summary of linezolid activity and resistance mechanisms detected during the 2012 LEADER surveillance program for the United States
    Mendes RE Antimicrob Agents Chemother 58 : 1243 ~ 1247 [2014]
  • Summary of linezolid activity and resistance mechanisms detected during the 2012 LEADER surveillance program for the United States
    Mendes RE Antimicrob Agents Chemother 58 1243-1247 [2014]
  • Skin and soft-tissue infections: classifying and treating a spectrum
    Rajan S Cleve Clin J Med 79 : 57 ~ 66 [2012]
  • Skin and soft-tissue infections: classifying and treating a spectrum
    Rajan S Cleve Clin J Med 79 57-66 [2012]
  • Sivextro (tedizolid) Prescribing information
    Cubist Pharmaceuticals [2014]
  • Sivextro (tedizolid) Prescribing information
    - [2014]
  • Pneumonia caused by methicillin-resistant Staphylococcus aureus
    Rubinstein E Clin Infect Dis 46 (S5) : S378 ~ 385 [2008]
  • Pneumonia caused by methicillin-resistant Staphylococcus aureus
    Rubinstein E Clin Infect Dis 46 S5 S378-385 [2008]
  • In vitro activity of tedizolid (TR-700) against linezolid-resistant staphylococci
    Rodríguez-Avial I J Antimicrob Chemother 67 : 167 ~ 169 [2012]
  • In vitro activity of tedizolid (TR-700) against linezolid-resistant staphylococci
    Rodríguez-Avial I J Antimicrob Chemother 67 167-169 [2012]
  • In vitro activity of TR-700, the antibacterial moiety of the prodrug TR-701, against linezolid-resistant strains
    Shaw KJ Antimicrob Agents Chemother 52 : 4442 ~ 4447 [2008]
  • In vitro activity of TR-700, the antibacterial moiety of the prodrug TR-701, against linezolid-resistant strains
    Shaw KJ Antimicrob Agents Chemother 52 4442-4447 [2008]
  • Guidance for industry: acute bacterial skin and skin structure infections: developing drugs for treatment
    US Food and Drug Administration US Food and Drug Administration [2010]
  • Comparative in vitro activities of torezolid (DA-7157) against clinical isolates of aerobic and anaerobic bacteria in South Korea
    Yum JH Antimicrob Agents Chemother 54 : 5381 ~ 5386 [2010]
  • Comparative in vitro activities of torezolid (DA-7157) against clinical isolates of aerobic and anaerobic bacteria in South Korea
    Yum JH Antimicrob Agents Chemother 54 5381-5386 [2010]
  • Clinical efficacy and correlation of clinical outcomes with in vitro susceptibility for anaerobic bacteria in patients with complicated intra-abdominal infections treated with moxifloxacin
    Goldstein EJ Clin Infect Dis 53 : 1074 ~ 1080 [2011]
  • Clinical efficacy and correlation of clinical outcomes with in vitro susceptibility for anaerobic bacteria in patients with complicated intra-abdominal infections treated with moxifloxacin
    Goldstein EJ Clin Infect Dis 53 1074-1080 [2011]
  • Antianaerobic antimicrobials: spectrum and susceptibility testing
    Brook I Clin Microbiol Rev 26 : 526 ~ 546 [2013]
  • Antianaerobic antimicrobials: spectrum and susceptibility testing
    Brook I Clin Microbiol Rev 26 526-546 [2013]
  • Activity of tedizolid (TR-700) against well-characterized methicillin-resistant Staphylococcus aureus strains of diverse epidemiological origins
    Thomson KS Antimicrob Agents Chemother 57 : 2892 ~ 2895 [2013]
  • Activity of tedizolid (TR-700) against well-characterized methicillin-resistant Staphylococcus aureus strains of diverse epidemiological origins
    Thomson KS Antimicrob Agents Chemother 57 2892-2895 [2013]